Skip to main content
TMO
NYSE Industrial Applications And Services

Thermo Fisher Details Shareholder Dissent on Executive Pay, Announces 2026 Compensation Program Changes and CEO Retention Grant

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$488.25
Mkt Cap
$181.355B
52W Low
$385.46
52W High
$643.99
52W Position info
27% above low
Off High info
24% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

TMO sits 27% above its 52-week low of $385.46.

Summary

Thermo Fisher Scientific disclosed that its 2025 executive compensation proposal received only 36% shareholder support, leading to significant changes in the 2026 long-term incentive program and a one-time $57.7 million CEO retention grant.


Key Events · Corporate Governance and Compliance · TMO

  • Shareholder Say-on-Pay Dissent

    The 2025 advisory vote on executive compensation received only 36% shareholder support, signaling significant investor dissatisfaction with current pay practices.

  • 2026 Compensation Program Overhaul

    In response to shareholder feedback, the company revised its 2026 long-term incentive program to include 3-year performance metrics, increased weighting for relative TSR and ROIC, and a commitment to limit one-time equity grants.

  • CEO Retention Grant Approved

    A one-time performance-based restricted stock unit award valued at $57.7 million was approved for CEO Marc N. Casper in May 2025, with cliff vesting in 2030 and deferred share delivery until 2033-2035, contingent on TSR performance.

  • Board Composition Change

    Director James C. Mullen is not standing for re-election, which will reduce the board size from 12 to 11 members effective at the 2026 Annual Meeting.


Analysis · TMO · Industrial Applications And Services

This DEF 14A filing reveals that Thermo Fisher Scientific's 2025 "say-on-pay" executive compensation proposal received only 36% shareholder support, indicating significant investor dissatisfaction. In response, the Compensation Committee has implemented material changes to the 2026 long-term incentive program, including shifting to 3-year performance metrics, increasing the weighting of relative Total Shareholder Return (TSR) and Return on Invested Capital (ROIC), and committing to fewer one-time equity grants. Concurrently, the Board approved a one-time $57.7 million performance-based restricted stock unit award for CEO Marc N. Casper in May 2025, designed for retention through 2030 with deferred share delivery until 2033-2035, contingent on TSR performance. This filing highlights a notable shift in executive compensation strategy driven by direct shareholder feedback.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 37.5% of the 3713 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, TMO was trading at $488.25 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $181.4B. The 52-week trading range was $385.46 to $643.99. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

TMO - Latest Insights

TMO
Nov 06, 2026, 10:21 AM EST
Source: Benzinga
Importance Score:
7
Price at Filing: $686.10
Real-time Price: $697.76 info
Change: +$11.66 (+2%) info
Market Cap: $258.396B info
TMO
Oct 30, 2026, 10:52 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $699.82
Real-time Price: $697.76 info
Change: -$2.06 (-0.29%) info
Market Cap: $258.396B info
TMO
Oct 21, 2026, 2:31 PM EDT
Source: Benzinga
Importance Score:
7
Price at Filing: $696.57
Real-time Price: $697.76 info
Change: +$1.19 (+0.17%) info
Market Cap: $258.396B info
TMO
Oct 21, 2026, 6:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $690.00
Real-time Price: $697.76 info
Change: +$7.76 (+1%) info
Market Cap: $258.396B info
TMO
Jul 31, 2026, 10:51 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $564.80
Real-time Price: $697.76 info
Change: +$132.96 (+24%) info
Market Cap: $258.396B info